Mckesson
McKesson Corporation, a leading player in the healthcare industry, is headquartered in California and operates extensively across North America. Founded in 1833, McKesson has evolved into a vital partner for healthcare providers, offering a comprehensive range of services including pharmaceutical distribution, healthcare management solutions, and technology integration. The company is renowned for its innovative approach to supply chain management and its commitment to improving patient care through advanced data analytics and pharmacy services. With a strong market position, McKesson consistently ranks among the top companies in the Fortune 500, reflecting its significant impact on the healthcare landscape. Its dedication to enhancing operational efficiency and patient outcomes sets McKesson apart as a trusted leader in the industry.
DitchCarbon Score
How does Mckesson's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Wholesale Trade industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mckesson's score of 45 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mckesson's reported carbon emissions
In 2023, McKesson Corporation reported total greenhouse gas emissions of approximately 28,980,752,000 kg CO2e, comprising 79,293,000 kg CO2e from Scope 1, 140,582,000 kg CO2e from Scope 2, and 28,980,752,000 kg CO2e from Scope 3 emissions. This reflects a commitment to reducing absolute Scope 1 and 2 emissions by 50.4% by FY2032, using FY2020 as the baseline year. Additionally, McKesson aims for 70% of its suppliers, by spend on purchased goods and services, to establish science-based targets by FY2027. Over the years, McKesson has demonstrated a proactive approach to climate commitments, with significant reductions in emissions from previous years. For instance, in 2020, the company reported 88,219,000 kg CO2e in Scope 1 and 189,365,000 kg CO2e in Scope 2 emissions, alongside a substantial Scope 3 total of approximately 25,426,174,000 kg CO2e. McKesson's initiatives align with industry standards for climate action, reflecting a commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company's targets are consistent with the reductions necessary to limit global warming to 1.5°C, showcasing its dedication to environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 92,194,000 | 00,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 188,912,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 28,733,000 | 00,000,000 | 00,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mckesson is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
